An2 Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $29k | 23k | 1.27 |
| 2025-06-30 | $13k | 13k | 1.06 |
| 2024-12-31 | $94k | 68k | 1.38 |
| 2024-06-30 | $3.3M | 1.6M | 2.15 |
| 2024-03-31 | $5.1M | 1.6M | 3.25 |
| 2023-12-31 | $32M | 1.6M | 20.49 |
| 2023-09-30 | $25M | 1.6M | 16.08 |
| 2023-06-30 | $11M | 1.3M | 8.50 |
| 2023-03-31 | $13M | 1.3M | 9.87 |
| 2022-12-31 | $13M | 1.3M | 9.53 |
| 2022-06-30 | $9.9M | 1.3M | 7.44 |
| 2022-03-31 | $21M | 1.4M | 14.50 |